Article Information
History
- July 16, 2020.
Article Versions
- Version 1 (October 18, 2019 - 07:30).
- Version 2 (October 25, 2019 - 14:24).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Niccolò Tesi1,2,3,
- Sven J. van der Lee1,2,
- Marc Hulsman1,2,3,
- Iris E. Jansen1,4,
- Najada Stringa5,6,
- Natasja M. van Schoor5,6,
- Philip Scheltens1,
- Wiesje M. van der Flier1,5,
- Martijn Huisman5,6,
- Marcel J. T. Reinders3 and
- Henne Holstege1,2,3,*
- 1Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
- 2Department of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands
- 3Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands
- 4Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, the Netherlands
- 5Department of Epidemiology and Biostatistics, Amsterdam UMC, Amsterdam, The Netherlands
- 6Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
- ↵*Corresponding Author Dr. Henne Holstege, Alzheimer’s Center Amsterdam, Amsterdam UMC, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands, Tel: +31 20 4440816, Email: h.holstege{at}amsterdamumc.nl
Posted July 16, 2020.
Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s Disease
